Edition:
United Kingdom

MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

19.41USD
18 Oct 2018
Change (% chg)

$-0.22 (-1.12%)
Prev Close
$19.63
Open
$19.57
Day's High
$19.57
Day's Low
$19.38
Volume
911
Avg. Vol
107,458
52-wk High
$32.57
52-wk Low
$16.16

Chart for

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology... (more)

Overall

Beta: 2.78
Market Cap(Mil.): $659.43
Shares Outstanding(Mil.): 36.80
Dividend: --
Yield (%): --

Financials

  MGNX.OQ Industry Sector
P/E (TTM): -- 85.83 33.69
EPS (TTM): -4.18 -- --
ROI: -49.45 0.58 14.30
ROE: -52.35 1.62 16.03

BRIEF-MacroGenics Posts Qtrly Net Loss Per Common Share Of $1.34

* MACROGENICS PROVIDES UPDATE ON CORPORATE PROGRESS AND 1ST QUARTER 2018 FINANCIAL RESULTS

07 May 2018

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF238.50 +2.50
Roche Holding Ltd. (RO.S) CHF239.00 +2.80
Amgen, Inc. (AMGN.OQ) $203.91 +1.14
Xencor Inc (XNCR.OQ) $35.58 -0.78

Earnings vs. Estimates